Pharvaris

We're a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help people living with hereditary angioedema (HAE) and other bradykinin-mediated diseases. Our team reunites many of the experts responsible for the discovery and approva…